Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 193

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 193
---
 malice in providing our services as follows:

(1) In case the conviction shall arise from information provided by the Client which the advisor explicitly relied on in performing the valuation – the client agreed to indemnify and reimburse 100% of any amount which the advisor shall be required to bear.

(2) Otherwise, the client agreed to indemnify and reimburse the advisor for amounts paid by the advisor which are exceeding 3 times the advisor’s fee.

In any event, we will update the Client and will allow it to plead its defense in any proceeding and we will not settle without its prior written consent. It is agreed that the Client will pay the amounts mentioned in this paragraph only if they exceed our professional services fees, and after deducting our fees.

| Moore Financial Consulting |

| Teli.Valuation | November 2025Page 3 of 24 |

Study performer: Tzach Kasuto, M.Sc.

Tzach is a partner at Moore Financial Consulting LTD. He has about 20 years of experience in consulting and management, including extensive experience in business, strategic and economic consulting. Tzach holds a bachelor’s degree in economics and an MBA from Tel Aviv University.

Areas of expertise: Company valuation, fairness opinions, common share valuation, purchase price allocations, employee stock option valuation, expert opinions, Feasibility Studies, and Pricing Analysis.

Recent projects include:

| ● | Fattal                                                                                              
 Hotels. Provided Fattal Hotels, a major European hotel & leisure company, with numerous             
 financial expert opinions, including a valuation and financial model requested by the underwriters, 
 in connection with Fattal’s IPO.                                                                    |
| ● | The                                                                                                 
 Second Authority for Television & Radio. Provided the Israeli Second Authority for                  
 Television & Radio with numerous economic studies and industry forecasts.                           |
| ● | El                                                                                                  
 Al. Provided El Al with valuations of two optional suppliers, which offered El Al an                
 equity shares as a benefit for selecting them as a supplier.                                        |
| ● | The                                                                                                 
 Israel Land Development Company. Provided the Israel Land Development Company, one of               
 the leading public companies in Israel, with numerous valuation studies of the company’s            
 major holdings.                                                                                     |
| ● | Given                                                                                               
 imaging. Various PPA and Impairment studies of Given Imaging SBUs (A global, leader in              
 patient-friendly solutions for visualizing, detecting, and monitoring GI disorders).                |
| ● | Kanit                                                                                               
 Hashalom. Numerous valuations of subsidiaries such as